-
2016 Fourth Quarter
Listen to the webcast View the press releaseWatch Sir Andrew Witty, CEO, and Simon Dingemans, CFO discuss our full year 2016 results. Watch Patrick Vallance, President, Pharmaceuticals R&D, give an update on R&D.
Related downloads
- Q4 2016 results announcement PDF - 1.8MB
- Q4 2016 analyst slide presentation PDF - 606.8KB
- Q4 2016 results transcript PDF - 76.6KB
- Q4 2016 results highlights infographic PDF - 895.6KB
- Q4 2016 US dollar translation PDF - 128.4KB
- Q4 2016 actual growth schedules PDF - 132.2KB
- Q4 2016 pre announcement aide memoire PDF - 1,020.8KB
-
2016 Third Quarter
Listen to the webcast View the press releaseWatch Sir Andrew Witty, CEO, discuss our third quarter results 2016.
-
2016 Second Quarter
Listen to the webcast View the press releaseWatch Sir Andrew Witty, CEO, and Simon Dingemans, CFO discuss our second quarter 2016 results. Watch Patrick Vallance, President, Pharmaceuticals R&D, give an update on R&D.
-
2016 First Quarter
Listen to the webcast View the press releaseWatch Sir Andrew Witty, CEO, and Simon Dingemans, CFO, discuss our first quarter 2016 results.
-
2015 Fourth Quarter
Listen to the webcast View the press releaseWatch Sir Andrew Witty, CEO, and Simon Dingemans, CFO, discuss our full year 2015 results. Watch Patrick Vallance, President, Pharmaceuticals R&D, give an update on R&D in 2015.
Related downloads
-
2015 Third Quarter
Listen to the webcast View the press releaseWatch Simon Dingemans, CFO, discuss our third quarter results 2015.
Other key information
-
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
-
Press releases
Keep up to date with our news and recent announcements
-
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business
-
Product pipeline
A snapshot of our medicines and vaccines currently in development across three stages: phase I, phase II and phase III
